Compare BPYPN & NOVTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Brookfield Property Partners L.P. 5.750% Cumulative Redeemable Perpetual Preferred Units Series 3
Current Price
| Metric | BPYPN | NOVTU |
|---|---|---|
| Founded | N/A | N/A |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Industrial Machinery/Components |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2012 | 1999 |
| Metric | BPYPN | NOVTU |
|---|---|---|
| Price | $13.10 | $60.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 56.9K | 3.9K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $73.77 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $12.99 | $47.57 |
| 52 Week High | $14.88 | $76.95 |
| Indicator | BPYPN | NOVTU |
|---|---|---|
| Relative Strength Index (RSI) | 31.36 | 48.80 |
| Support Level | $13.00 | $58.53 |
| Resistance Level | $13.97 | $61.73 |
| Average True Range (ATR) | 0.18 | 1.32 |
| MACD | -0.04 | 0.30 |
| Stochastic Oscillator | 1.49 | 40.52 |
Brookfield Property Partners LP owns and operates in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.